1 not yet recruiting. .
Follow Ahmed Mohammed Hussein Sayed: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Risk Factors of Failure of Conservative Treatment in Acute Non Complicated Appendicitis ceftriaxone, ceftriaxone 1 gm/12 hourly and IV metronidazole 500 mg/8 hourly - Conservative Management | Not yet recruiting | Ahmed Mohammed Hussein Sayed | 100 | 2025-06-22 | 2025-02-17 |
Appendicitis (1)
Ceftriaxone (1) · Metronidazole (1)
Egypt (1)